Source:http://linkedlifedata.com/resource/pubmed/id/21334412
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-25
|
pubmed:abstractText |
Buforin IIb is a novel cell-penetrating anticancer peptide derived from histone H2A. In this study, we enhanced the cancer targeting specificity of buforin IIb using a tumor-associated enzyme-controlled activation strategy. Buforin IIb was fused with an anionic peptide (modified magainin intervening sequence, MMIS), which neutralizes the positive charge of buforin IIb and thus renders it inactive, via a matrix metalloproteinases (MMPs)-cleavable linker. The resulting MMIS:buforin IIb fusion peptide was completely inactive against MMPs-nonproducing cells. However, when the fusion peptide was administrated to MMPs-producing cancer cells, it regained the killing activity by releasing free buforin IIb through MMPs-mediated cleavage. Moreover, the activity of the fusion peptide toward MMPs-producing cancer cells was significantly decreased when the cells were pretreated with a MMP inhibitor. Taken together, these data indicate that the cancer targeting specificity of MMIS:buforin IIb is enhanced compared to the parent peptide by reactivation at the specialized areas where MMPs are pathologically produced.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/buforin II
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1873-5169
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
895-9
|
pubmed:meshHeading |
pubmed-meshheading:21334412-Cell Line, Tumor,
pubmed-meshheading:21334412-Cells, Cultured,
pubmed-meshheading:21334412-HeLa Cells,
pubmed-meshheading:21334412-Hemolysis,
pubmed-meshheading:21334412-Humans,
pubmed-meshheading:21334412-Matrix Metalloproteinase 2,
pubmed-meshheading:21334412-Matrix Metalloproteinase 9,
pubmed-meshheading:21334412-Neoplasms,
pubmed-meshheading:21334412-Peptides,
pubmed-meshheading:21334412-Proteins,
pubmed-meshheading:21334412-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker.
|
pubmed:affiliation |
Department of Biology, Research Institute of Life Science, Gyeongsang National University, 900 Gajwa-dong, Jinju 660-701, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|